| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/24/1989 | EP0316818A2 Monoclonal antibodies capable of recognizing N-acetylneuraminic acid in beta-arrangement |
| 05/24/1989 | EP0316776A2 Monoclonal antibodies to anthracyclines |
| 05/24/1989 | EP0316748A2 Process for the selective cleavage of fusion proteins |
| 05/24/1989 | EP0316725A2 Process for the enzymatic synthetis of peptides containing at least one non-proteic aminoacid, and peptides derived from this synthesis |
| 05/24/1989 | EP0316712A2 22-Dechloroteicoplanins |
| 05/24/1989 | EP0316695A1 Recombinant HIV-2 polypeptides |
| 05/24/1989 | EP0316462A1 Murine hybridoma Lym-2 and diagnostic antibody produced thereby |
| 05/24/1989 | EP0316425A1 A SV40 EXPRESSION VECTOR CONTAINING HBxAg AS AN EXPRESSION MARKER |
| 05/24/1989 | CN1033074A Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 05/24/1989 | CN1033073A Method for promoting intramolecular bond fisulfide bormation in recombinant proteins contained in denaturant solution |
| 05/24/1989 | CN1033072A Recombinant dna-derived bordetella toxin subvnit analogs |
| 05/24/1989 | CN1033071A Monoclonal antibody specific to hiv antigens |
| 05/24/1989 | CN1033070A Modified plasminogen activators |
| 05/23/1989 | US4833127 Novel CSF and method for obtaining the same |
| 05/23/1989 | US4833085 Monoclonal antibody specific for human colon fibroblast-derived t-PA |
| 05/23/1989 | US4833076 Antitumor agents |
| 05/23/1989 | US4833071 Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor |
| 05/23/1989 | US4832959 Preparation of polypeptides having human γ-interferon activity |
| 05/23/1989 | CA1254527A1 Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods |
| 05/18/1989 | WO1989004491A1 Urinary assay for measuring bone resorption |
| 05/18/1989 | WO1989004486A1 Diagnostic methods and systems for quantifying apo ai |
| 05/18/1989 | WO1989004376A1 Monoclonal antibody specific to hiv antigens |
| 05/18/1989 | WO1989004370A1 Human monoclonal anti-hiv-i-antibodies |
| 05/18/1989 | WO1989004367A1 Method of purifying recombinant proteins from corresponding host cell proteins |
| 05/18/1989 | WO1989004365A1 Microorganism having low acetate forming capability and its application |
| 05/18/1989 | WO1989004327A1 Human monoclonal antibody against aspergilli |
| 05/18/1989 | WO1989004326A1 Alveolar surfactant proteins |
| 05/18/1989 | WO1989004325A1 Neutrophil-activating polypeptide, process for its manufacture and its use as a drug and diagnosticum |
| 05/18/1989 | WO1989004324A1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 05/18/1989 | WO1989004209A1 Emulsifiers |
| 05/18/1989 | WO1989004175A1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 05/18/1989 | WO1989004174A1 Anti-c3bi receptor (cr3) antibodies and therapeutic composition |
| 05/18/1989 | WO1989003846A3 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/18/1989 | DE3737917A1 Phosphorylierte derivate von cardiodilatin/anf-peptiden Phosphorylated derivatives of cardiodilatin / anf-peptides |
| 05/18/1989 | DE3737703A1 Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum Neutrophil-activating polypeptide moved to its production and its use as a drug and diagnostic use |
| 05/17/1989 | EP0316306A2 Monoclonal antibodies special for HB A1c |
| 05/17/1989 | EP0316229A1 Microorganism having low acetate forming capability, and process for production of useful substrate using same |
| 05/17/1989 | EP0316170A2 Method for the identification of antigens expressed in vivo, diagnostic assays therefor and vaccines containing them |
| 05/17/1989 | EP0316115A2 Novel voctors and expression sequences for production of polypeptides |
| 05/17/1989 | EP0316068A1 Modified low molecular weight plasminogen activator and method of preparation |
| 05/17/1989 | EP0315950A2 Method of incubating cells expressing a recombinant protein |
| 05/17/1989 | EP0315782A2 Method for the production of proteins |
| 05/17/1989 | EP0315683A1 Dna sequences, recombinant dna molecules and processes for producing lymphocyte function associated antigen-3 |
| 05/17/1989 | EP0315680A1 Antibody combining sites that exhibit stereoselective synthase activity, and methods using the same |
| 05/17/1989 | EP0315650A1 Purification of recombinant interleukin-1. |
| 05/16/1989 | US4831121 Polydisperse native pseudomonas flagellar (H) antigens (FAg) and methods of producing them |
| 05/16/1989 | US4831120 Method for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cell |
| 05/16/1989 | US4830852 Covalent-modification and having a coupling spacer containing a thioether; vaccines; chemical stability; infant protection |
| 05/16/1989 | EP0228452A4 Protein purification. |
| 05/16/1989 | CA1254161A1 Herpes virus specific immunological materials and methods |
| 05/10/1989 | EP0315456A2 Polysaccharide-modified immunoglobulins having reduced immunogenic potential or improved pharmacokinetics |
| 05/10/1989 | EP0315254A1 Protein 7B2, recombinant DNA, cDNA and mRNA, and a method of detecting the mRNA |
| 05/10/1989 | EP0315242A2 Process for purifying recombinant hepatitis antigens |
| 05/10/1989 | EP0315118A2 DNA coding for endothelin and use thereof |
| 05/10/1989 | EP0315085A2 Recombinant histidine-rich protein from Plasmodium falciparum, its synthesis and use |
| 05/10/1989 | EP0315081A2 Anti-coagulating protein PP4-x, its preparation and use |
| 05/10/1989 | EP0315062A2 Production of chimeric antibodies by homologous recombination |
| 05/10/1989 | EP0314862A1 Immunogenic conjugates comprising cyclosporins |
| 05/10/1989 | EP0314861A1 Labeled derivatives of cyclosporins |
| 05/10/1989 | EP0314744A1 Monokine dosing. |
| 05/10/1989 | CN1032816A Monoclonal antibodies against human interleukin-4 and hybridomas producing same |
| 05/09/1989 | US4828990 Zinc or copper salt, polyethylenimine |
| 05/09/1989 | US4828989 Process for purifying a protein |
| 05/09/1989 | US4828988 Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine |
| 05/09/1989 | US4828986 Elisa; monoclonal paratopic molecules secreted by hydbridomas to immunoreact |
| 05/09/1989 | US4828981 Competitive, homogeneous or heterogeneous |
| 05/09/1989 | CA1253816A1 Monoclonal antibodies against alveolar surfactant protein |
| 05/09/1989 | CA1253777A1 Nucleic acid hybridization assay employing immobilized rna probes |
| 05/05/1989 | WO1989003996A1 Human gamma, delta t cell antigen receptor polypeptides and nucleic acids |
| 05/05/1989 | WO1989003993A1 Paired helical filament core and antibody thereto useful in diagnosing alzheimer's disease |
| 05/05/1989 | WO1989003887A1 A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
| 05/05/1989 | WO1989003886A1 Expression systems for preparation of polypeptides in prokaryotic cells |
| 05/05/1989 | WO1989003884A1 Interleukin-7 |
| 05/05/1989 | WO1989003883A1 Enhancement of cell growth by expression of a cloned hemoglobin gene |
| 05/05/1989 | WO1989003881A1 Nonglycosylated analogs of human colony stimulating factors |
| 05/05/1989 | WO1989003877A1 Integration and expression viral vectors |
| 05/05/1989 | WO1989003846A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/05/1989 | WO1989003845A1 Ps2 protein derivative |
| 05/05/1989 | WO1989003840A1 Method of purifying protein |
| 05/05/1989 | WO1989003836A1 Factors associated with essential hypertension |
| 05/05/1989 | WO1989003674A1 Microspheres, way of producing said microspheres and the use thereof |
| 05/03/1989 | EP0314569A1 Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus |
| 05/03/1989 | EP0314534A1 Expression vector for proteins from the HIV-2 virus, one of the agents that cause AIDS |
| 05/03/1989 | EP0314496A2 Improved hybridoma production |
| 05/03/1989 | EP0314415A2 Interleukin-7 |
| 05/03/1989 | EP0314402A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/03/1989 | EP0314317A1 Adheson variants, nucleic acid encoding them and compositions comprising them |
| 05/03/1989 | EP0314240A2 Process for purifying recombinant hepatitis antigens |
| 05/03/1989 | EP0314161A1 Human immunoglobulines produced by recombinant DNA techniques |
| 05/03/1989 | EP0314096A2 Methods of regulating protein glycosylation |
| 05/03/1989 | EP0313641A1 Activation antigen |
| 05/03/1989 | DE3833897A1 Klonierung und expression des transforming growth faktor-(beta)2 Cloning and expression of transforming growth factor (beta) 2 |
| 05/03/1989 | CN1032661A Method of purifying protein |
| 05/02/1989 | US4826957 Immunogenic recombinant yeast expression product and method for purifying it |
| 05/02/1989 | US4826764 Enhancing the translational initiation frequency of a gene |
| 05/02/1989 | US4826763 Genetically transformed saccharomyces |
| 05/02/1989 | US4826624 Dispersing liquid hydrocarbon into a second liquid |
| 04/27/1989 | DE3734632A1 Process for the preparation of t-PA |
| 04/26/1989 | EP0313538A2 Monoclonal antibody, a process for its preparation and the use thereof |
| 04/26/1989 | EP0313377A1 Process for purification of soluble T4 |